Sight Diagnostics raises $71m to boost commercial operations
Israeli diagnostics company Sight Diagnostics has raised $71m in a Series D funding round to commercialise the global launch of finger-prick complete blood count (CBC) analyser.
Kavya Chivukula
Latest articles
All Articles
FDA clears Abbott’s Gallant devices for cardiac arrhythmia
Abbott has received the US Food and Drug Administration (FDA) approval for its Gallant implantable cardioverter-defibrillator (ICD) and cardiac…
Vapotherm to expand nasal cannula production in response to Covid-19
Vapotherm is set to scale up capital equipment manufacturing capabilities to increase the production of its Precision Flow systems.
2019 top news stories
Brain-computer interface could translate thoughts into speech and US regulator sought additional details on $4.2bn Boston Scientific-BTG deal. Medicaldevice-network.com…
Royal Philips receives FDA approval for drug-coated balloons
The US Food and Drug Administration (FDA) has approved two variants of Royal Philips’ 200mm and 150mm Stellarex 0.035”…
September’s top news stories
World-first cardio trial showed reduced wait times and hospital admissions and Orchestra gets CE-Mark for Moderato system to treat…
Varian to invest in Oncora to develop radiation oncology tools
Varian will invest in privately held digital health company Oncora Medical to accelerate the development of precision medicine in…
iRhythm, Verily teams up to develop diagnostic tools for AFib
iRhythm Technologies has collaborated with Alphabet’s health venture Verily to develop new technology for screening, diagnosing and managing atrial…
Angle initiates main phase of ovarian cancer testing platform study
UK-based liquid biopsy company Angle has initiated the main phase of its ovarian cancer test study and enrolled its…